Establishment of a new canine inflammatory mammary carcinoma cell line and analysis of its cystine-glutamate transporter subunit expression

1Bonnet D., Dick J.E.: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3, 730–737, doi: 10.1038/nm0797-730. Bonnet D. Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 1997 3 730 737 10.1038/nm0797-7309212098Open DOISearch in Google Scholar

2Boughey J.C., Gonzalez R.J., Bonner E., Kuerer H.M.: Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 2007, 12, 1276–1287, doi: 10.1634/theoncologist.12-11-1276. Boughey J.C. Gonzalez R.J. Bonner E. Kuerer H.M. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast Oncologist 2007 12 1276 1287 10.1634/theoncologist.12-11-127618055847Open DOISearch in Google Scholar

3Caceres S., Pena L., de Andres P.J., Illera M.J., Lopez M.S., Woodward W.A., Reuben J.M., Illera J.C.: Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366. PLoS One 2015, 10, e0122277, doi: 10.1371/journal.pone.0122277. Caceres S. Pena L. de Andres P.J. Illera M.J. Lopez M.S. Woodward W.A. Reuben J.M. Illera J.C. Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366 PLoS One 2015 10 e0122277 10.1371/journal.pone.0122277437385825807360Open DOISearch in Google Scholar

4Caceres S., Pena L., Lacerda L., Illera M.J., de Andres P.J., Larson R.A., Gao H., Debeb B.G., Woodward W.A., Reuben J.M., Illera J.C.: Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer. Vet Comp Oncol 2017, 15, 980–995, doi: 10.1111/vco.12238. Caceres S. Pena L. Lacerda L. Illera M.J. de Andres P.J. Larson R.A. Gao H. Debeb B.G. Woodward W.A. Reuben J.M. Illera J.C. Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer Vet Comp Oncol 2017 15 980 995 10.1111/vco.1223827146723Open DOISearch in Google Scholar

5de Mello Souza C.H., Toledo-Piza E., Amorin R., Barboza A., Tobias K.M.: Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Can Vet J 2009, 50, 506–510. de Mello Souza C.H. Toledo-Piza E. Amorin R. Barboza A. Tobias K.M. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment Can Vet J 2009 50 506 510Search in Google Scholar

6Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G.: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1, 555–567, doi: 10.1016/j.stem.2007.08.014. Ginestier C. Hur M.H. Charafe-Jauffret E. Monville F. Dutcher J. Brown M. Jacquemier J. Viens P. Kleer C.G. Liu S. Schott A. Hayes D. Birnbaum D. Wicha M.S. Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 2007 1 555 567 10.1016/j.stem.2007.08.014242380818371393Open DOISearch in Google Scholar

7Hance K.W., Anderson W.F., Devesa S.S., Young H.A., Levine P.H.: Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005, 97, 966–975, doi: 10.1093/jnci/dji172. Hance K.W. Anderson W.F. Devesa S.S. Young H.A. Levine P.H. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute J Natl Cancer Inst 2005 97 966 975 10.1093/jnci/dji172284493715998949Open DOISearch in Google Scholar

8Ishimoto T., Nagano O., Yae T., Tamada M., Motohara T., Oshima H., Oshima M., Ikeda T., Asaba R., Yagi H., Masuko T., Shimizu T., Ishikawa T., Kai K., Takahashi E., Imamura Y., Baba Y., Ohmura M., Suematsu M., Baba H., Saya H.: CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011, 19, 387–400, doi: 10.1016/j.ccr.2011.01.038. Ishimoto T. Nagano O. Yae T. Tamada M. Motohara T. Oshima H. Oshima M. Ikeda T. Asaba R. Yagi H. Masuko T. Shimizu T. Ishikawa T. Kai K. Takahashi E. Imamura Y. Baba Y. Ohmura M. Suematsu M. Baba H. Saya H. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth Cancer Cell 2011 19 387 400 10.1016/j.ccr.2011.01.03821397861Open DOISearch in Google Scholar

9Jergens A.E., Schreiner C.A., Frank D.E., Niyo Y., Ahrens F.E., Eckersall P.D., Benson T.J., Evans R.: A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003, 17, 291–297, doi: 10.1111/j.1939-1676.2003.tb02450.x. Jergens A.E. Schreiner C.A. Frank D.E. Niyo Y. Ahrens F.E. Eckersall P.D. Benson T.J. Evans R. A scoring index for disease activity in canine inflammatory bowel disease J Vet Intern Med 2003 17 291 297 10.1111/j.1939-1676.2003.tb02450.x12774968Open DOISearch in Google Scholar

10Kurebayashi J., Yamamoto S., Otsuki T., Sonoo H.: Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect. Br J Cancer 1999, 79, 631–636, doi: 10.1038/sj.bjc.6690099. Kurebayashi J. Yamamoto S. Otsuki T. Sonoo H. Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect Br J Cancer 1999 79 631 636 10.1038/sj.bjc.6690099236242610027341Open DOISearch in Google Scholar

11Marcato P., Dean C.A., Pan D., Araslanova R., Gillis M., Joshi M., Helyer L., Pan L., Leidal A., Gujar S., Giacomantonio C.A., Lee P.W.: Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011, 29, 32–45, doi: 10.1002/stem.563. Marcato P. Dean C.A. Pan D. Araslanova R. Gillis M. Joshi M. Helyer L. Pan L. Leidal A. Gujar S. Giacomantonio C.A. Lee P.W. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis Stem Cells 2011 29 32 45 10.1002/stem.56321280157Open DOISearch in Google Scholar

12Maruo T., Kanemaki N., Onda K., Sato R., Ichihara N., Ochiai H.: Canine amino acid transport system Xc(-): cDNA sequence, distribution and cystine transport activity in lens epithelial cells. J Vet Med Sci 2014, 76, 523–530, doi: 10.1292/jvms.13-0170. Maruo T. Kanemaki N. Onda K. Sato R. Ichihara N. Ochiai H. Canine amino acid transport system Xc(-): cDNA sequence, distribution and cystine transport activity in lens epithelial cells J Vet Med Sci 2014 76 523 530 10.1292/jvms.13-0170406413624366150Open DOISearch in Google Scholar

13Michishita M., Akiyoshi R., Suemizu H., Nakagawa T., Sasaki N., Takemitsu H., Arai T., Takahashi K.: Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines. Vet J 2012, 193, 508–513, doi: 10.1016/j.tvjl.2012.01.006. Michishita M. Akiyoshi R. Suemizu H. Nakagawa T. Sasaki N. Takemitsu H. Arai T. Takahashi K. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines Vet J 2012 193 508 513 10.1016/j.tvjl.2012.01.00622326935Open DOISearch in Google Scholar

14Michishita M., Akiyoshi R., Yoshimura H., Katsumoto T., Ichikawa H., Ohkusu-Tsukada K., Nakagawa T., Sasaki N., Takahashi K.: Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines. Res Vet Sci 2011, 91, 254–260, doi: 10.1016/j.rvsc.2010.11.016. Michishita M. Akiyoshi R. Yoshimura H. Katsumoto T. Ichikawa H. Ohkusu-Tsukada K. Nakagawa T. Sasaki N. Takahashi K. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines Res Vet Sci 2011 91 254 260 10.1016/j.rvsc.2010.11.01621190702Open DOISearch in Google Scholar

15Moreb J.S.: Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 2008, 3, 237–246, doi: 10.2174/ 157488808786734006. Moreb J.S. Aldehyde dehydrogenase as a marker for stem cells Curr Stem Cell Res Ther 2008 3 237 246 10.2174/15748880878673400619075754Open DOISearch in Google Scholar

16Mu Z., Klinowska T., Dong X., Foster E., Womack C., Fernandez S.V., Cristofanilli M.: AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models. J Exp Clin Cancer Res 2014, 33, 47, doi: 10.1186/1756-9966-33-47. Mu Z. Klinowska T. Dong X. Foster E. Womack C. Fernandez S.V. Cristofanilli M. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models J Exp Clin Cancer Res 2014 33 47 10.1186/1756-9966-33-47406151324886365Open DOISearch in Google Scholar

17Nishikawa S., Konno M., Hamabe A., Hasegawa S., Kano Y., Ohta K., Fukusumi T., Sakai D., Kudo T., Haraguchi N., Satoh T., Takiguchi S., Mori M., Doki Y., Ishii H.: Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. Int J Oncol 2013, 42, 1437–1442, doi: 10.3892/ijo.2013.1837. Nishikawa S. Konno M. Hamabe A. Hasegawa S. Kano Y. Ohta K. Fukusumi T. Sakai D. Kudo T. Haraguchi N. Satoh T. Takiguchi S. Mori M. Doki Y. Ishii H. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy Int J Oncol 2013 42 1437 1442 10.3892/ijo.2013.183723440340Open DOISearch in Google Scholar

18Okazaki S., Shintani S., Hirata Y., Suina K., Semba T., Yamasaki J., Umene K., Ishikawa M., Saya H., Nagano O.: Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells. Oncotarget 2018, 9, 33832–33843, doi: 10.18632/oncotarget.26112. Okazaki S. Shintani S. Hirata Y. Suina K. Semba T. Yamasaki J. Umene K. Ishikawa M. Saya H. Nagano O. Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells Oncotarget 2018 9 33832 33843 10.18632/oncotarget.26112617346830333913Open DOISearch in Google Scholar

19Otsubo K., Nosaki K., Imamura C.K., Ogata H., Fujita A., Sakata S., Hirai F., Toyokawa G., Iwama E., Harada T., Seto T., Takenoyama M., Ozeki T., Mushiroda T., Inada M., Kishimoto J., Tsuchihashi K., Suina K., Nagano O., Saya H., Nakanishi Y., Okamoto I.: Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer. Cancer Sci 2017, 108, 1843–1849, doi: 10.1111/cas.13309. Otsubo K. Nosaki K. Imamura C.K. Ogata H. Fujita A. Sakata S. Hirai F. Toyokawa G. Iwama E. Harada T. Seto T. Takenoyama M. Ozeki T. Mushiroda T. Inada M. Kishimoto J. Tsuchihashi K. Suina K. Nagano O. Saya H. Nakanishi Y. Okamoto I. Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer Cancer Sci 2017 108 1843 1849 10.1111/cas.13309558151628667792Open DOISearch in Google Scholar

20Perez Alenza M.D., Tabanera E., Pena L.: Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J Am Vet Med Assoc 2001, 219, 1110–1114, doi: 10.2460/javma.2001.219.1110. Perez Alenza M.D. Tabanera E. Pena L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999) J Am Vet Med Assoc 2001 219 1110 1114 10.2460/javma.2001.219.111011700710Open DOISearch in Google Scholar

21Reya T., Morrison S.J., Clarke M.F., Weissman I.L.: Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105–111, doi: 10.1038/35102167. Reya T. Morrison S.J. Clarke M.F. Weissman I.L. Stem cells, cancer, and cancer stem cells Nature 2001 414 105 111 10.1038/3510216711689955Open DOISearch in Google Scholar

22Ruiu R., Rolih V., Bolli E., Barutello G., Riccardo F., Quaglino E., Merighi I.F., Pericle F., Donofrio G., Cavallo F., Conti L.: Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter. Cancer Immunol Immunother 2019, 68, 131–141, doi: 10.1007/s00262-018-2185-1. Ruiu R. Rolih V. Bolli E. Barutello G. Riccardo F. Quaglino E. Merighi I.F. Pericle F. Donofrio G. Cavallo F. Conti L. Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter Cancer Immunol Immunother 2019 68 131 141 10.1007/s00262-018-2185-129947961Open DOISearch in Google Scholar

23Sharma M.K., Seidlitz E.P., Singh G.: Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun 2010, 391, 91–95, doi: 10.1016/j.bbrc.2009.10.168. Sharma M.K. Seidlitz E.P. Singh G. Cancer cells release glutamate via the cystine/glutamate antiporter Biochem Biophys Res Commun 2010 391 91 95 10.1016/j.bbrc.2009.10.16819896463Open DOISearch in Google Scholar

24Shirakawa K., Tsuda H., Heike Y., Kato K., Asada R., Inomata M., Sasaki H., Kasumi F., Yoshimoto M., Iwanaga T., Konishi F., Terada M., Wakasugi H.: Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res 2001, 61, 445–451. Shirakawa K. Tsuda H. Heike Y. Kato K. Asada R. Inomata M. Sasaki H. Kasumi F. Yoshimoto M. Iwanaga T. Konishi F. Terada M. Wakasugi H. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer Cancer Res 2001 61 445 451Search in Google Scholar

25Sun S., Wang Z.: ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis. Biochem Biophys Res Commun 2010, 396, 843–848, doi: 10.1016/j.bbrc.2010.04.170. Sun S. Wang Z. ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis Biochem Biophys Res Commun 2010 396 843 848 10.1016/j.bbrc.2010.04.17020450887Open DOISearch in Google Scholar

26Tanabe A., Kimura K., Tazawa H., Maruo T., Taguchi M., Sahara H.: Functional analysis of CD44 variants and xCT in canine tumours. Vet Med Sci 2021, 7, 577–585, doi: 10.1002/vms3.397. Tanabe A. Kimura K. Tazawa H. Maruo T. Taguchi M. Sahara H. Functional analysis of CD44 variants and xCT in canine tumours Vet Med Sci 2021 7 577 585 10.1002/vms3.397802562333210459Open DOISearch in Google Scholar

27Timmerman L.A., Holton T., Yuneva M., Louie R.J., Padro M., Daemen A., Hu M., Chan D.A., Ethier S.P., van ’t Veer L.J., Polyak K., McCormick F., Gray J.W.: Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 2013, 24, 450–465, doi: 10.1016/j.ccr.2013.08.020. Timmerman L.A. Holton T. Yuneva M. Louie R.J. Padro M. Daemen A. Hu M. Chan D.A. Ethier S.P. van ’t Veer L.J. Polyak K. McCormick F. Gray J.W. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target Cancer Cell 2013 24 450 465 10.1016/j.ccr.2013.08.020393131024094812Open DOISearch in Google Scholar

28Uyama R., Nakagawa T., Hong S.H., Mochizuki M., Nishimura R., Sasaki N.: Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression. Vet Comp Oncol 2006, 4, 104–113, doi: 10.1111/j.1476-5810.2006.00098.x. Uyama R. Nakagawa T. Hong S.H. Mochizuki M. Nishimura R. Sasaki N. Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression Vet Comp Oncol 2006 4 104 113 10.1111/j.1476-5810.2006.00098.x19754820Open DOISearch in Google Scholar

29Van den Eynden G.G., Van Laere S.J., Van der Auwera I., Merajver S.D., Van Marck E.A., van Dam P., Vermeulen P.B., Dirix L.Y., van Golen K.L.: Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 2006, 95, 219–228, doi: 10.1007/s10549-005-9002-1. Van den Eynden G.G. Van Laere S.J. Van der Auwera I. Merajver S.D. Van Marck E.A. van Dam P. Vermeulen P.B. Dirix L.Y. van Golen K.L. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer Breast Cancer Res Treat 2006 95 219 228 10.1007/s10549-005-9002-116244790Open DOISearch in Google Scholar

30Vassalli G.: Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells. Stem Cells Int 2019, 2019, 3904645, doi: 10.1155/2019/3904645. Vassalli G. Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells Stem Cells Int 2019 2019 3904645 10.1155/2019/3904645634881430733805Open DOISearch in Google Scholar

31Visvader J.E., Stingl J.: Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev 2014, 28, 1143–1158, doi: 10.1101/gad.242511.114. Visvader J.E. Stingl J. Mammary stem cells and the differentiation hierarchy: current status and perspectives Genes Dev 2014 28 1143 1158 10.1101/gad.242511.114405276124888586Open DOISearch in Google Scholar

32Xiao Y., Ye Y., Yearsley K., Jones S., Barsky S.H.: The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol 2008, 173, 561–574, doi: 10.2353/ajpath.2008.071214. Xiao Y. Ye Y. Yearsley K. Jones S. Barsky S.H. The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype Am J Pathol 2008 173 561 574 10.2353/ajpath.2008.071214247579218599608Open DOISearch in Google Scholar

33Yae T., Tsuchihashi K., Ishimoto T., Motohara T., Yoshikawa M., Yoshida G.J., Wada T., Masuko T., Mogushi K., Tanaka H., Osawa T., Kanki Y., Minami T., Aburatani H., Ohmura M., Kubo A., Suematsu M., Takahashi K., Saya H., Nagano O.: Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun 2012, 3, 883, doi: 10.1038/ncomms1892. Yae T. Tsuchihashi K. Ishimoto T. Motohara T. Yoshikawa M. Yoshida G.J. Wada T. Masuko T. Mogushi K. Tanaka H. Osawa T. Kanki Y. Minami T. Aburatani H. Ohmura M. Kubo A. Suematsu M. Takahashi K. Saya H. Nagano O. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell Nat Commun 2012 3 883 10.1038/ncomms189222673910Open DOISearch in Google Scholar

34Yamauchi H., Woodward W.A., Valero V., Alvarez R.H., Lucci A., Buchholz T.A., Iwamoto T., Krishnamurthy S., Yang W., Reuben J.M., Hortobagyi G.N., Ueno N.T.: Inflammatory breast cancer: what we know and what we need to learn. Oncologist 2012, 17, 891–899, doi: 10.1634/theoncologist.2012-0039. Yamauchi H. Woodward W.A. Valero V. Alvarez R.H. Lucci A. Buchholz T.A. Iwamoto T. Krishnamurthy S. Yang W. Reuben J.M. Hortobagyi G.N. Ueno N.T. Inflammatory breast cancer: what we know and what we need to learn Oncologist 2012 17 891 899 10.1634/theoncologist.2012-0039339964322584436Open DOISearch in Google Scholar

35Zhou Y., Yang J., Chen C., Li Z., Chen Y., Zhang X., Wang L., Zhou J.: Polyphyllin -Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT. Front Pharmacol 2021, 12, 670224, doi: 10.3389/fphar.2021.670224. Zhou Y. Yang J. Chen C. Li Z. Chen Y. Zhang X. Wang L. Zhou J. Polyphyllin -Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT Front Pharmacol 2021 12 670224 10.3389/fphar.2021.670224814181834040532Open DOISearch in Google Scholar